BREAKING NEWS : Full Story

Experts skeptical after researchers report positive vaccine results

CNN's Elizabeth Cohen responds to Dr. Deborah Birx's comments about a new hydroxychloroquine study during a White House press briefing.

Posted: May 23, 2020 5:01 PM
Updated: May 23, 2020 5:01 PM

Researchers in China reported results from one of the first Covid-19 vaccine trials Friday, but experts who spoke to CNN were skeptical of their findings and called the data lukewarm.

In a study published in the medical journal The Lancet, researchers said their vaccine was well-tolerated and generated an immune response against the novel coronavirus.

The vaccine, developed by CanSino Biological Inc. and the Beijing Institute of Biotechnology, was tested in 108 healthy adults ages 18 to 60 in Wuhan, China, none of whom were infected with the virus.

All the participants received injections at low, middle or high doses, and no "serious" side effects were reported, according to Wei Chin of the Beijing Institute of Biotechnology and colleagues, who ran the trial.

Weak responses

Still, almost half of vaccine recipients reported fever, with 44% reporting fatigue and 39% reporting a headache. Overall, 9% of patients reported side effects that were severe enough to have potentially "prevented activity."

These side effects are "not a good safety sign," said Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia.

In addition, he said, the vaccine did not elicit a strong immune response.

According to the study, about half of recipients in the low- and middle-dose groups developed neutralizing antibodies, which can bind to the coronavirus and neutralize its effects.

About three-quarters of people in the high-dose group developed antibodies, but researchers also noted some severe side effects in that group. They said they won't be giving such a high dose in future studies.

Offit said the immunogenicity data was "not impressive," especially since all of the doses -- even the "low" dose -- were actually very high, he said. Combined with the side effects, he recommended that the CanSino researchers give up on their efforts.

"I think they should stop," said Offit, who previously developed a successful rotavirus vaccine. "I have to believe there are other candidates out there that are going to do better than this."

Dr. Peter Hotez, dean of the National School of Tropical Medicine at the Baylor College of Medicine, also wasn't thrilled with the findings. "I'm not impressed with this," he said.

Still, he said researchers should keep studying the vaccine, either to use on its own or alongside another vaccine in what's called a prime-boost approach.

"The good news is, (the vaccine) is producing neutralizing antibodies, which scientists think is important for protective immunity against Covid-19," said Hotez, who is also working on a vaccine against Covid-19. "What is less certain is whether the levels of neutralizing antibody are high enough to confer complete protection, or whether this will be partially protective."

Clinical trial in China will study 500 volunteers

The vaccine from the Beijing researchers uses what's called an adenovirus vector. Adenoviruses can cause the common cold, but in this case, they're weakened and modified to deliver genetic material that codes for a protein from the novel coronavirus.

The body then produces that protein and, ideally, develops an immune response against it. In the new study, the vaccine produced a complex immune response, prompting most volunteers to produce both T-cells that should attack the coronavirus and antibodies as well.

This particular vaccine used an adenovirus strain called adenovirus 5. People who had some immunity to that strain did not seem to respond as well to the vaccine, the researchers said.

Chen called the results encouraging but said more research is needed.

"The trial demonstrates that a single dose of the new adenovirus type 5 vectored COVID-19 (Ad5-nCoV) vaccine produces virus-specific antibodies and T cells in 14 days, making it a potential candidate for further investigation," he said.

"However, these results should be interpreted cautiously. The challenges in the development of a COVID-19 vaccine are unprecedented, and the ability to trigger these immune responses does not necessarily indicate that the vaccine will protect humans from COVID-19."

He said the result "shows a promising vision for the development of COVID-19 vaccines, but we are still a long way from this vaccine being available to all."

According to The Lancet's press release, researchers have initiated a randomized, double-blind, placebo-controlled trial in Wuhan, China to further test the vaccine -- the gold standard for clinical research.

The study will look at 500 healthy adults, according to the Lancet, with half of the volunteers given the middle dose, 125 given the low dose, and 125 given a placebo. The research will include participants over 60 years old.

The vaccine is just one of many in development. There are currently 10 in human trials around the world, with four in the US, five in China -- including CanSino -- and one in the UK. More than 100 vaccines are also in preclinical trials, according to the World Health Organization.

Indiana Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 48524

Reported Deaths: 2698
CountyConfirmedDeaths
Marion11682684
Lake5180242
Elkhart330146
Allen2798132
St. Joseph196466
Cass16389
Hamilton1563101
Hendricks1410100
Johnson1288118
Porter73237
Tippecanoe7268
Madison65964
Clark65544
Bartholomew58644
LaPorte58026
Howard57757
Kosciusko5494
Vanderburgh5486
Marshall4904
Noble48228
Jackson4723
LaGrange4709
Hancock45035
Boone44543
Delaware44550
Shelby42625
Floyd38144
Morgan32931
Monroe30028
Grant29526
Montgomery29420
Clinton2892
Henry27415
Dubois2736
White26510
Decatur25032
Lawrence24625
Dearborn23823
Vigo2358
Harrison21822
Warrick21829
Unassigned193193
Greene18932
Miami1832
Jennings17611
Putnam1698
DeKalb1624
Scott1627
Daviess14317
Wayne1406
Orange13623
Perry1299
Steuben1292
Franklin1248
Jasper1212
Ripley1177
Wabash1122
Carroll1102
Fayette997
Newton9810
Starke933
Whitley925
Gibson812
Huntington812
Randolph794
Wells731
Fulton721
Jefferson722
Jay680
Washington671
Pulaski661
Knox640
Clay604
Rush583
Adams501
Owen491
Benton480
Sullivan451
Posey420
Brown391
Spencer381
Blackford372
Crawford320
Fountain322
Tipton321
Switzerland270
Parke230
Martin220
Ohio170
Vermillion140
Warren141
Union130
Pike110

Ohio Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 57956

Reported Deaths: 2927
CountyConfirmedDeaths
Franklin10410429
Cuyahoga7883373
Hamilton6019198
Lucas2752302
Marion273438
Pickaway219741
Summit2143206
Montgomery203427
Mahoning1832232
Butler159944
Columbiana130760
Stark1123112
Lorain103567
Trumbull96770
Warren86021
Clark7669
Delaware58215
Fairfield57216
Tuscarawas56710
Belmont54922
Medina52332
Lake50018
Licking49312
Miami46631
Portage44258
Ashtabula43544
Wood42851
Clermont4146
Geauga40742
Wayne36351
Richland3455
Allen32141
Mercer2829
Greene2589
Darke25125
Erie24422
Holmes2363
Huron2202
Madison1978
Ottawa14923
Sandusky13614
Crawford1355
Washington13520
Putnam12815
Ross1273
Hardin12312
Morrow1161
Coshocton1112
Auglaize1074
Monroe8917
Jefferson882
Union861
Muskingum831
Hancock791
Hocking788
Guernsey743
Preble731
Lawrence710
Williams712
Clinton680
Shelby684
Logan621
Fulton610
Ashland591
Athens591
Carroll593
Wyandot596
Brown571
Defiance513
Knox511
Fayette460
Highland451
Scioto410
Champaign401
Perry351
Van Wert350
Seneca342
Henry300
Paulding250
Adams241
Jackson230
Pike230
Vinton222
Gallia181
Harrison121
Meigs120
Morgan110
Noble110
Unassigned00
Fort Wayne
Clear
88° wxIcon
Hi: 80° Lo: 70°
Feels Like: 91°
Angola
Clear
90° wxIcon
Hi: 91° Lo: 69°
Feels Like: 90°
Huntington
Broken Clouds
83° wxIcon
Hi: 90° Lo: 69°
Feels Like: 86°
Decatur
Clear
77° wxIcon
Hi: 91° Lo: 70°
Feels Like: 79°
Van Wert
Clear
77° wxIcon
Hi: 91° Lo: 70°
Feels Like: 79°
Hot Wednesday
WFFT Radar
WFFT Temperatures
WFFT National

Community Events